Herb Profile

Ficus Carica

Ficus carica

Ficus Carica (Ficus carica) carries a Grade C rating — limited evidence.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution Fig latex can trigger allergy or skin irritation; caution with latex/fruit allergy, diabetes medications, anticoagulants, pregnancy/breastfeeding, and concentrated latex or leaf extracts. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Antioxidant, Hormonal, Stress resilience, Inflammatory signaling
Avoid / review if
Pregnancy/Breastfeeding Without Clinician Supervision, Known Allergy To The Plant/Family, Hormone Sensitive Conditions Without Clinician Review
Ficus Carica monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Fig latex can trigger allergy or skin irritation; caution with latex/fruit allergy, diabetes medications, anticoagulants, pregnancy/breastfeeding, and concentrated latex or leaf extracts.
Profile context
antioxidant, hormonal
Next steps

Continue reading

Safety

Safety & Cautions

Fig latex can trigger allergy or skin irritation; caution with latex/fruit allergy, diabetes medications, anticoagulants, pregnancy/breastfeeding, and concentrated latex or leaf extracts.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Hormonal Activity ContextHormone-adjacent wording is present and should be interpreted carefully.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Pregnancy/Breastfeeding Without Clinician Supervision
  • Known Allergy To The Plant/Family
  • Hormone Sensitive Conditions Without Clinician Review
  • Potential Interaction Concern With Hormonal Therapies
  • Immunosuppressants
  • Use Clinician Review For High Dose Extracts Or Chronic Use.

Safety classifications

  • Interaction-Aware: Medication or interaction context is explicitly noted.
  • Hormonal Activity Context: Hormone-adjacent wording is present and should be interpreted carefully.
  • Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

  • Fig latex can trigger allergy or skin irritation; caution with latex/fruit allergy, diabetes medications, anticoagulants, pregnancy/breastfeeding, and concentrated latex or leaf extracts.

Safety labels

  • Interaction-Aware
  • Hormonal Activity Context
  • Pregnancy/Breastfeeding Caution

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedOxidative Stress Modulation · Hormonal Signaling Context · NF KB Modulation

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableFig latex can trigger allergy or skin irritation; caution with latex/fruit allergy, diabetes medications, anticoagulants, pregnancy/breastfeeding, and concentrated latex or leaf extracts.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Narrative review
Risk of Bias
High
Consistency
Not assessed
Strongest recorded design is a narrative review, drawn from 2 recorded studies, none of which measured an outcome in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (3)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 3 of 3 studies.

What the evidence actually shows

This table contains 3 structured sources, including 0 human evidence sources; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Effects of Common Fig (Ficus carica L.) and Its Extracts on Certain Cancer Types: Focusing on the Mechanism of Action

Gökçen EN et al. · Int J Mol Sci · 2025

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Physicochemistry, Nutritional, and Therapeutic Potential of Ficus carica - A Promising Nutraceutical

Fazel MF et al. · Drug Des Devel Ther · 2024

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Fig-derived exosome-like nanoparticles attenuating bone metastasis of breast cancer through establishing an anti-tumor microenvironment

Wang DD et al. · Pharmacol Res · 2026

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Preparation varies by tradition and product form and require source backed dosage review before therapeutic claims.
How Ficus Carica works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Ficus Carica Works

How Ficus Carica WorksFicus Carica acts on biological target pathways via antioxidant, leading to antioxidant efct.Ficus CaricaBiological TargetBiological pathwayAntioxidantAntioxidant EfctCell protectionHormonal SignalingContext
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Oxidative Stress Modulation
  • Hormonal Signaling Context
  • NF KB Modulation

Active Compounds

Key constituents studied in Ficus Carica, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Ficus Carica

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Ficus Carica research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.